Trials / Completed
CompletedNCT03776968
A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics
A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics in Healthy Chinese Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Hinova Pharmaceuticals Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a phase I study evaluating HC-1119 single-dose pharmacokinetics and effect of food on its pharmacokinetics in healthy Chinese adults. The study primary objective is to evaluate the HC-1119 pharmacokinetic characteristics and the effect of food on its pharmacokinetics in healthy Chinese males, subsequent to a single oral administration of HC-1119 with different doses in healthy Chinese males.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HC1119 | oral |
Timeline
- Start date
- 2017-10-24
- Primary completion
- 2018-01-15
- Completion
- 2018-07-03
- First posted
- 2018-12-17
- Last updated
- 2024-10-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03776968. Inclusion in this directory is not an endorsement.